Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04965818
Title Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Taiho Oncology, Inc.

lung non-small cell carcinoma

Advanced Solid Tumor


Binimetinib + Futibatinib

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.